Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc) Meeting Abstract


Authors: Slovin, S. F.; Fine, S.; Nelson, P.; Steinbrecher, J.; Eastham, J.; Coleman, J.; Touijer, K. A.; Carver, B. S.; Laudone, V.; Scher, H. I.
Abstract Title: Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Language: English
ACCESSION: WOS:000208852001138
DOI: 10.1200/jco.2010.28.15_suppl.e15133
PROVIDER: wos
Notes: Meeting Abstract: e15133 -- Source: Wos
Altmetric Score
MSK Authors
  1. Jonathan Coleman
    181 Coleman
  2. Vincent Laudone
    59 Laudone
  3. Susan Slovin
    181 Slovin
  4. Abdelkrim Karim Touijer
    190 Touijer
  5. James Eastham
    422 Eastham
  6. Brett Stewart Carver
    108 Carver
  7. Samson W Fine
    314 Fine
  8. Howard Scher
    792 Scher